Yubo International Biotech Limited
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a YBGJ research report →
Price Chart
About the company
Yubo International Biotech Limited, operating through its various subsidiaries, primarily dedicates its efforts to the research, development, and practical application of endometrial stem cells. Beyond this core focus, the company also provides a diverse range of products, including solutions for respiratory health, skincare and hair care formulations, nutritious beverages, and personal care items tailored for both men and women. Furthermore, it delivers specialized stem cell services, such as cellular analysis and comprehensive health management consulting, all offered under the VIVCELL brand.
- CEO
- Yang Wang
- IPO
- 2021
- Employees
- 14
- HQ
- Beijing, BE, CN
Get TickerSpark's AI analysis on YBGJ
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $886.16K
- P/E
- -0.80
- PEG
- -0.11
- P/S
- 6.59
- P/B
- -0.34
- EV/EBITDA
- -0.83
- Div Yield
- 0.00%
- Gross Margin
- 28.01%
- Op Margin
- -743.23%
- Net Margin
- -694.87%
- ROE
- 43.75%
- ROIC
- 32.28%
Latest fiscal year · YoY change
- Revenue
- $134.39K+3772.9%
- Gross Profit
- $8.16K+103.9%
- Op Income
- $-1,187,696
- Net Income
- $-1,079,248+39.2%
- EPS
- $-0.01+48.0%
- OCF Growth
- +37.0%
- FCF Growth
- +37.0%
- 52W High
- $0.02
- 52W Low
- $0.00
- 50D MA
- $0.01
- 200D MA
- $0.01
- Beta
- 0.71
- RSI (14)
- 36
- Avg Volume
- 4.06K
No earnings-call transcripts are available for YBGJ yet.
- Free Float
- 8.8%
- Shares Outstanding
- 170.42M
- Float Shares
- 14.99M
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jul 23, 25 | Wang Jun | other | 42,000,000 |
| Jul 23, 25 | Wang Yang | other | 8,600,000 |
| Jan 25, 24 | Boao Biotech Ltd | sell | 500,000 |
| Jan 25, 24 | Boao Biotech Ltd | sell | 741,521 |
| Jan 25, 24 | Boao Biotech Ltd | sell | 301,701 |
| Jan 25, 24 | Boao Biotech Ltd | sell | 364,351 |
| Jan 25, 24 | Boao Biotech Ltd | sell | 181,256 |
| Jan 25, 24 | Boao Biotech Ltd | sell | 86,897 |
| Jan 25, 24 | Boao Biotech Ltd | sell | 426,654 |
| Jan 25, 24 | Boao Biotech Ltd | sell | 2,057,586 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our YBGJ coverage
Recent articles, reports, and earnings notes.
No research on YBGJ yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate YBGJ report →